GSC
CELGZ

Ground Swell Capital’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Ground Swell Capital’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-400
Closed -$1K – 3231
2014
Q2 		$1K Buy
+400
New +$1.11K ﹤0.01% 1951

Other funds holding CELGZ

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
PC
Pomelo Capital New York $1.04B AUM 1.25% 1-Year Est. Return
WJA
Williams Jones & Associates New York $4.82B AUM 19.95% 1-Year Est. Return

Ground Swell Capital's CELGZ Position: Q3 2014 in Review

Ground Swell Capital sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q3 2014, closing a stake of 400 shares — an estimated $1K sold.

Ground Swell Capital first reported a position in CELGZ in Q2 2014 and held it in 1 quarter. The position peaked at $1K in Q2 2014. 23 funds tracked by Wall St. Rank hold CELGZ as of Q3 2014.

  • Ground Swell Capital reported no remaining Celgene Corporation Contingent Value Rights position as of Q3 2014 after selling out during the quarter.
  • Ground Swell Capital sold 400 Celgene Corporation Contingent Value Rights shares in Q3 2014, an estimated $1K.
  • Ground Swell Capital first reported a position in Celgene Corporation Contingent Value Rights in Q2 2014 and held it in 1 quarter.
  • Ground Swell Capital's Celgene Corporation Contingent Value Rights position peaked at $1K in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.